Itaconate-Related Gene Signatures as Prognostic Markers in Colon Cancer: Insights From Transcriptomic and Spatial Analysis. (PubMed, Hum Mutat) - Jan 12, 2026 - "Drug sensitivity analysis identified four potentially effective drugs, such as sepantronium bromide, which had better effects on high-risk patients. This study provides a theoretical basis and new targets for precise prognosis and stratified treatment of colon cancer."
Biomarker • Gene Signature • IO biomarker • Journal • Tumor mutational burden • Colon Cancer • Colorectal Cancer • Oncology • Solid Tumor • CD36 • CDKN2A • CXCL1 • INHBB • SCARB1 • TIMP1 • TMB
|
|
Chen Bai; Denggang Chen; Hailang Wei; Hui Li; Jianchao Meng; Peng Zhang; Qingyun Wang; Sujit Nair; Tingting Zhang
|